Aktis Oncology, Inc. (AKTS)
NASDAQ: AKTS · Real-Time Price · USD
29.44
-1.71 (-5.49%)
At close: Jun 26, 2026, 4:00 PM EDT
30.02
+0.58 (1.97%)
After-hours: Jun 26, 2026, 6:54 PM EDT
Aktis Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy Initiates $40 | Buy | Initiates | $40 | +35.87% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +18.89% | Jun 2, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $34 | Buy | Maintains | $34 | +15.49% | Jun 1, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 11, 2026 |
| Leerink Partners | Leerink Partners | Buy Initiates $31 | Buy | Initiates | $31 | +5.30% | Feb 3, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +1.90% | Feb 3, 2026 |